EverQuote director awarded 9,105 RSUs
EverQuote, Inc. director John L. Shields reported a stock-based compensation grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EverQuote, Inc. director John L. Shields reported a stock-based compensation grant. He acquired 9,105 restricted stock units (RSUs), each representing one share of Class A Common Stock upon vesting. These RSUs are scheduled to vest quarterly over one year, beginning on April 4, 2026.
Following this award, Shields directly holds 34,324 shares of Class A Common Stock. The reported transaction reflects a grant/award at no cash purchase price, typical of director equity compensation rather than an open-market share purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 9,105 | $0.00 | $0.00 |
Footnotes (1)
- F1. Consists of shares of Class A Common Stock issuable under 9,105 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock upon vesting. These RSUs are scheduled to vest quarterly over one year, beginning April 4, 2026.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Class A Common Stock financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did EverQuote (EVER) director John L. Shields report?
How do the new EverQuote (EVER) RSUs for John L. Shields vest?
Was there a cash price paid for the EverQuote (EVER) RSU grant to John L. Shields?
Is John L. Shields’ EverQuote (EVER) Form 4 transaction a buy or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.